December 11, 2025
Article
CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma.
Knowledge Isn’t Enough When Action Costs Too Much
What Does Minimal Residual Disease Mean?
Preoperative Breast MRI Did Not Improve Outcomes in Early-Stage Breast Cancer
Enhertu/Perjeta Combo Enhances Quality of in HER2+ Advanced Breast Cancer